Predictive value of apolipoprotein E genotyping in Alzheimer's disease: Results of an autopsy series and an analysis of several combined studies

Apoliprotein E (apoE) is associated with Alzheimer's neurofibrillary tangles and β‐amyloid protein in senile plaques. Recent studies have shown an increased frequency of the ϵ4 allele of the apoE gene in familial and sporadic cases of Alzheimer's disease (AD). In the present case control study, we have determined the apoE genotype by allele‐specific extension of 113 postmortem cases of sporadic AD and 77 control brains shown to be free of AD neuropathological features and then calculated the frequency of the various allelic forms of apoE (ϵ2, ϵ3,ϵ4). The odds ratio associating ϵ4 with AD was 15.5 (95% confidence interval {CI} 6.2–38.5), and the population attributable risk was 0.53. We have also combined the results of our study and several others to calculate these same parameters in a larger population (570 controls and 961 AD subjects); the odds ratio for this larger group was 6.2 (95% CI 4.9–7.8) and the population attributable risk was 0.57. These results further substantiate and strengthen the association between the ϵ4 allele of apoE gene and AD. We have also used these results to investigate the usefulness of the determination of ϵ4 carrier status in the diagnosis of AD.

[1]  P. Froguel,et al.  Genetic associations with human longevity at the APOE and ACE loci , 1994, Nature Genetics.

[2]  J. Hill,et al.  Improved phenotyping of apolipoprotein E: application to population frequency distribution. , 1990, Clinical chemistry.

[3]  Thomas Wisniewski,et al.  Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid , 1992, Neuroscience Letters.

[4]  S. Gauthier,et al.  Comparative Alterations of Nicotinic and Muscarinic Binding Sites in Alzheimer's and Parkinson's Diseases , 1992, Journal of neurochemistry.

[5]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[6]  S. Gauthier,et al.  Apolipoprotein E polymorphism and Alzheimer's disease , 1993, The Lancet.

[7]  G. Siest,et al.  Apolipoprotein E-∈A allele and Alzheimer's disease , 1993, The Lancet.

[8]  S. Gauthier,et al.  Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats , 1993, Neuroscience.

[9]  C. Finch,et al.  Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. , 1991, Brain research. Molecular brain research.

[10]  U. Roessmann,et al.  Parkinson disease, dementia, and alzheimer disease: Clinicopathological correlations , 1980, Annals of neurology.

[11]  B. Tycko,et al.  The apolipoprotein ε4 allele in patients with Alzheimer's disease , 1993, Annals of neurology.

[12]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. MacGillivray,et al.  Apolipoprotein E genotyping using the polymerase chain reaction and allele-specific oligonucleotide primers. , 1991, Journal of lipid research.

[14]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[15]  C. Finch,et al.  Cloning of hippocampal poly(A) RNA sequences that increase after entorhinal cortex lesion in adult rat. , 1991, Brain research. Molecular brain research.

[16]  D L Price,et al.  Aminergic systems in Alzheimer's disease and Parkinson's disease , 1987, Annals of neurology.

[17]  B. Vogelstein,et al.  Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. , 1985, Biochemical and biophysical research communications.

[18]  João Nicanildo Bastos dos Santos.  Movement of the rhabditiform larva of Strongyloides stercoralis , 1993, The Lancet.

[19]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[20]  J. Eldor.  Immediate intracardiac adrenaline injection in asystole , 1993, The Lancet.

[21]  S. Mirra,et al.  Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients , 1987, Neurology.

[22]  Z. Khachaturian.  Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.

[23]  B. Hyman,et al.  Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions , 1993, Neuron.

[24]  E. Otomo,et al.  Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease , 1991, Brain Research.